has_radio_last_6_months
Codelist metadata
-
Coding system
- OPCS-4
-
Coding system release
- unknown
-
Organisation
- QCovid
-
Codelist ID
- qcovid/has_radio_last_6_months
-
Version ID
- 6732f71c
Versions
About
Description
OPCS codelist for the has_radio_last_6_months
group in the QCovid® to develop the
COVID-19 Population Risk Assessment.
References
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
code | term |
---|---|
A613 | Radiotherapy to lesion of peripheral nerve |
C395 | Radiotherapy to lesion of conjunctiva |
C823 | External beam radiotherapy to lesion of retina |
C824 | Plaque radiotherapy to lesion of retina |
J123 | Selective internal radiotherapy with microspheres to lesion of liver |
M706 | Radioactive seed implantation into prostate |
M712 | Implantation of radioactive substance into prostate |
P205 | Implantation of radioactive substance into vagina |
Q151 | Introduction of radioactive substance into uterine cavity |
X65 | Radiotherapy delivery |
X651 | Delivery of a fraction of total body irradiation |
X652 | Delivery of a fraction of intracavitary radiotherapy |
X653 | Delivery of a fraction of interstitial radiotherapy |
X654 | Delivery of a fraction of external beam radiotherapy NEC |
X655 | Oral delivery of radiotherapy for thyroid ablation |
X656 | Delivery of a fraction of intraluminal brachytherapy |
X657 | Delivery of radionuclide therapy NEC |
X658 | Other specified radiotherapy delivery |
X659 | Unspecified radiotherapy delivery |
Y35 | Introduction of removable radioactive material into organ NOC |
Y351 | Introduction of radioactive caesium into organ NOC |
Y352 | Introduction of iridium wire into organ NOC |
Y353 | Introduction of radium into organ NOC |
Y354 | Introduction of radioactive substance into organ for brachytherapy NOC |
Y358 | Other specified introduction of removable radioactive material into organ NOC |
Y359 | Unspecified introduction of removable radioactive material into organ NOC |
Y36 | Introduction of non-removable material into organ NOC |
Y361 | Introduction of gold seeds into organ NOC |
Y362 | Introduction of therapeutic implant into organ NOC |
Y363 | Radioactive seed implantation NOC |
Y364 | Introduction of non-removable radioactive substance into organ for brachytherapy NOC |
Y368 | Other specified introduction of non-removable material into organ NOC |
Y369 | Unspecified introduction of non-removable material into organ NOC |
Y91 | External beam radiotherapy |
Y911 | Megavoltage treatment for complex radiotherapy |
Y912 | Megavoltage treatment for simple radiotherapy |
Y913 | Superficial or orthovoltage treatment for radiotherapy |
Y914 | Megavoltage treatment for adaptive radiotherapy |
Y915 | Megavoltage treatment for hypofractionated stereotactic radiotherapy |
Y918 | Other specified external beam radiotherapy |
Y919 | Unspecified external beam radiotherapy |
A613 | Radiotherapy to lesion of peripheral nerve |
C395 | Radiotherapy to lesion of conjunctiva |
C823 | External beam radiotherapy to lesion of retina |
C824 | Plaque radiotherapy to lesion of retina |
J123 | Selective internal radiotherapy with microspheres to lesion of liver |
M706 | Radioactive seed implantation into prostate |
M712 | Implantation of radioactive substance into prostate |
P205 | Implantation of radioactive substance into vagina |
Q151 | Introduction of radioactive substance into uterine cavity |
X65 | Radiotherapy delivery |
X651 | Delivery of a fraction of total body irradiation |
X652 | Delivery of a fraction of intracavitary radiotherapy |
X653 | Delivery of a fraction of interstitial radiotherapy |
X654 | Delivery of a fraction of external beam radiotherapy NEC |
X655 | Oral delivery of radiotherapy for thyroid ablation |
X656 | Delivery of a fraction of intraluminal brachytherapy |
X657 | Delivery of radionuclide therapy NEC |
X658 | Other specified radiotherapy delivery |
X659 | Unspecified radiotherapy delivery |
Y35 | Introduction of removable radioactive material into organ NOC |
Y351 | Introduction of radioactive caesium into organ NOC |
Y352 | Introduction of iridium wire into organ NOC |
Y353 | Introduction of radium into organ NOC |
Y354 | Introduction of radioactive substance into organ for brachytherapy NOC |
Y358 | Other specified introduction of removable radioactive material into organ NOC |
Y359 | Unspecified introduction of removable radioactive material into organ NOC |
Y36 | Introduction of non-removable material into organ NOC |
Y361 | Introduction of gold seeds into organ NOC |
Y362 | Introduction of therapeutic implant into organ NOC |
Y363 | Radioactive seed implantation NOC |
Y364 | Introduction of non-removable radioactive substance into organ for brachytherapy NOC |
Y368 | Other specified introduction of non-removable material into organ NOC |
Y369 | Unspecified introduction of non-removable material into organ NOC |
Y91 | External beam radiotherapy |
Y911 | Megavoltage treatment for complex radiotherapy |
Y912 | Megavoltage treatment for simple radiotherapy |
Y913 | Superficial or orthovoltage treatment for radiotherapy |
Y914 | Megavoltage treatment for adaptive radiotherapy |
Y915 | Megavoltage treatment for hypofractionated stereotactic radiotherapy |
Y918 | Other specified external beam radiotherapy |
Y919 | Unspecified external beam radiotherapy |